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Abstract: 
The study objective was to determine the effect of feeding corn oil or fish oil to horses on plasma 
fatty acid profiles and leukotriene B (LTB) synthesis by stimulated peripheral blood neutrophils. 
Two groups of horses (n = 5) were randomly assigned to diets supplemented with either 3.0% 
(by weight) corn oil or fish oil for a period of 14 weeks. The ratio of (n-6) to (n-3) fatty acids in 
oil supplements was 68.1 : 1 for corn oil and 0.12: 1 for fish oil. Production of LIB, and LIB, by 
peripheral blood neutrophils stimulated with calcium ionophore A23187 and plasma cholesterol, 
triacylglycerol, and α-tocopherol concentrations were measured. oil supplements was 68.1 : 1 for 
corn oil and 0.12: 1 for fish oil. Production of LIB, and LIB, by peripheral blood neutrophils 
stimulated with calcium ionophore A23187 and plasma cholesterol, triacylglycerol, and α-
tocopherol concentrations were measured. At 12 weeks, horses fed fish oil had increased plasma 
concentrations of eicosapentaenoic acid (27-fold; 8.5 versus 0.3 g/100 g fatty acids; P < .0001), 
docosahexaenoic acid (34-fold; 5.1 versus 0.1 g/100 g fatty acids; P < .0001), and arachidonic 
acid (8.3- fold; 4.1 versus 0.5 g/100 g fatty acids; P < .0001) compared with horses fed corn oil. 
Neutrophils from horses fed fish oil produced 78-fold (P = .01) more LTB5 and 9.5-fold (P = 
.003) more LTB, compared with predietary levels, and 17.6-fold (P = .01) and 3.3-fold (P = .02), 
respectively, more than horses fed corn oil, and the ratio of LIB, to LIB, concentrations was 4.0- 
fold (P = .002) higher in horses fed fish oil. This study suggests that dietary polyunsaturated fatty 
acids modulate the leukotriene inflammatory response of horses. If the ratio of LTB5 to LIB, 
concentrations is important in determining how inflammatory processes are mediated, then fish 
oil supplementation may have value in treatment of equine inflammatory diseases. 
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Linoleic acid and α-linolenic acid, both essential fatty acid and α-linolenic acid, both essential 
fatty  acids, are the respective precursors of the (n-6) and (n-3) series of fatty acids. Mammals 
lack enzymes to introduce double bonds at carbon atoms before the ninth carbon atom in the 
fatty acid chain, counting from the methyl end, and therefore, these fatty acids must be supplied 
in the diet.' z Linoleic acid, an (n-6) polyunsaturated fatty acid (PUFA), is found in corn, 
safflower, and soybean oils, whereas α-linolenic acid, an (n-3) PUFA, is found in linwhereas α-
linolenic acid, an (n-3) PUFA, is found in linseed, canola, and soybean oils. Further metabolism 
of linoleic acid (eg, elongation and desaturation) produces arachidonic acid (AA), which is 
subsequently incorporated into cell membrane phospholipids. Further metabolism of α-linolenic 
acid produces eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are also 
incorporated into cell membrane phospholipids. In fish oil, the predominant (n-3) fatty acids are 
EPA and DHA. It is believed that by increasing the amount of dietary (n-3) PUFA relative to (n-
6) PUFA, that (n-3) fatty acids are preferentially incorporated into cell membrane phospholipids 
compared with (n-6) fatty acids.
1-6 
 
When cells are activated by a chemical or physical insult, fatty acids are mobilized from cell 
membrane phospholipids and metabolized into eicosanoids, which mediate inflammatory 
processes. Further metabolism of AA by cyclooxygenase leads to production of proinflammatory 
eicosanoids of the 2-series (eg, thromboxane A2 and prostaglandin [PG] E2), whereas further 
metabolism of AA by lipoxygenase yields the 4-series eicosanoids (eg, leukotriene [LT] B4).
2-7
 
PGE2 has a number of proinflammatory effects, including induction of fever and erythema, 
increased vascular permeability and vasodilation, and enhancement of pain and edema caused by 
other agents such as bradykinin and histamine. PGE2 also regulates the production of cytokines 
by immune cells. Leukotrienes have chemotactic properties and are involved in regulation of 
inflammatory and immune processes. Leukotrienes of the 4 series regulate cytokine production. 
 
Alternatively, further metabolism of EPA produces less inflammatory eicosanoids of the 3 and 5 
series (eg, thromboxane A3, PG3, and LTB5).
2-7
 The eicosanoids produced from EPA are often 
less biologically potent than analogues synthesized from AA. For example, LTB5 is 10-fold less 
potent as a neutrophil chemoattractant than LTB4.
3-7
 Thus, the type of eicosanoids that cells 
produce, and consequently, communication between cells of the immune system, can potentially 
be modulated through dietary supplementation of essential fatty acids.
3-7 
 
The goals of this investigation were (1) to determine whether plasma fatty acid profiles, serum 
lipids, or serum biochemistries are altered by dietary fatty acid supplementation in horses similar 
to that observed in other species; and (2) to determine the effect of feeding different amounts of 
(n-3) fatty acids on leukotriene production by stimulated peripheral blood neutrophils from 
horses. We wanted to determine whether dietary supplementation with fish oil reduced 
expression of proinflammatory leukotrienes in healthy horses. To achieve this goal, we measured 
LTB4 and LTB5 production in calcium-ionophore-stimulated peripheral blood neutrophils of 
horses fed either corn oil or fish oil. 
 
Table 1. Composition of selected fatty acids of the oils used in the two horse experimental diets. 
 
 
MATERIALS AND METHODS 
Animals 
Ten mature light-breed mares ranging in age from 5 to 20 years (those fed corn oil, 12.4 ± 0.7 
years; those fed fish oil, 13.8 ± 2.9 years; mean ± SEM) and weighing between 429 and 553 kg 
(mean 502 kg) were selected for this study from the teaching herd at the College of Veterinary 
Medicine, Oregon State University, Corvallis, OR. All mares were nonpregnant and nonlactating 
throughout the duration of the study. Horses were determined to be healthy on the basis of 
physical examinations, complete blood counts, and serum biochemical evaluations completed at 
study initiation and throughout the study duration. All horses had been dewormed every other 
month and vaccinated according to current recommendations for encephalomyelitis, tetanus, in-
fluenza, and rhinopneumonitis. A commercially available oral paste dewormera was used to 
control internal parasites. 
 
Diets 
Experimental diets were designed to be isocaloric and isonitrogenous with all other minerals and 
vitamins equal between groups and balanced to meet or exceed current National Research 
Council recommendations for maintenance.
8
 The two experimental diets differed only in the oil 
source used to manipulate the proportion of (n-3) and (n-6) fatty acids. Diets contained either 
feed-grade Menhaden fish oil
a
 for the (n-3) enriched diet, or corn oil
c
 for the (n-6) enriched diet 
(Table 1). Oils were refrigerated and containers were capped with nitrogen. Peroxide values and 
p-anisidine values, a measure of the al dehyde content of fat, were measured to assess the degree 
of oil per- oxidation.
9 
 
Dietary components (on an as-fed basis) included grass hay (86.0%), beet pulp (10.1%), either 
corn oil or fish oil (3.0%), vitamin- mineral supplement' (0.6%), and limestone (0.3%). White 
salt was freely available to all mares. Grass hay, beet pulp, and oils were obtained from single 
sources in sufficient quantity to last for the study duration. Calculated nutrient composition (dry 
matter basis) of experimental diets based on individual feed analyses
e
 was 8.5% crude protein, 
2.2 Mcal/kg digestible energy, 4.9% ether extract, 56.0% neutral detergent fiber, 35.2% acid 
detergent fiber, 0.34% calcium, and 0.25% phosphorus. Mares were expected to consume 
between 7.7 and 9.5 kg of dry matter per day depending on body weight. Beet pulp, oil, and 
mineral sources were fed at a defined set amount, whereas hay intake was allowed to fluctuate to 
meet daily needs. With the allowed variation in hay intake, based on body weight differences, fat 
sources contributed between 12 and 15% of digestible energy calories (2.45 Mcal/d). Both grass 
hay (2.0% ether extract) and beet pulp (0.6% ether extract) feeds contained <2.0% total fatty 
acids; therefore, supplemental oil sources accounted for >98% of dietary fatty acids consumed. 
 
Horses were acclimated to a diet containing beet pulp without oil for 2 weeks before the study 
initiation. During the dietary intervention period, mares were allowed access to an exercise area 
and provided hay ad libitum during the day and housed in stalls in the evening when study diet 
supplements were fed. Beet pulp (0.91 kg as fed) was soaked in water for 6 to 8 hours before 
being mixed with either corn oil or fish oil (272 g; approximately 300 mL). Total (n-3) fatty 
acids comprised 0.88% of total dietary fatty acids (2.3 g/d) for horses fed the corn oil supplement 
and 27.2% (49.6 g/d) for horses fed the fish oil supplement. Oils were warmed to room 
temperature before feeding. Vitamin-mineral supplement (56 g) and limestone (15 g) were also 
added to the beet pulp and oil mixture. Horses were fed the supplement mixture in the afternoon, 
feed buckets remained in the stalls overnight, and food consumption was assessed the following 
morning. 
 
Study Design 
Horses were randomly assigned to 1 of 2 feeding groups (n = 5). Horses were fed oil-
supplemented diets for a period of 14 weeks following the diet acclimation period. Oil 
supplements were discontinued at 14 weeks. The time from week 14 to week 18 served as a 
washout period. Dietary supplement consumption was recorded daily throughout the feeding 
period. Body weights were recorded once prestudy, weeldy during the first 3 weeks of the 
feeding trial, and then biweeldy through week 12. Jugular venous blood was collected into tubes 
with and without ethylenediamine tetraacetic acid at 0, 6, 8, 12, and 18 weeks. Plasma was stored 
at —70°C until plasma fatty acid profiles and cholesterol, triacylglycerol, and α-tocopherol 
concentrations were and cholesterol, triacylglycerol, and α-tocopherol concentrations were 
determined. The experimental protocol was reviewed and approved by the Oregon State 
University Animal Care and Use Committee according to principles outlined by the National 
Institutes of Health.
10 
 
In addition to collection of peripheral blood (for studies reported in this paper), we also 
investigated selected immune responses in vivo, and selected immune responses of cells isolated 
from airways of these horses. These results are reported in a companion paper.
11
 Horses were 
challenged with a foreign protein (keyhole limpet hemocyanin) at 8 and 10 weeks after initiation 
of the feeding trial. A delayed-type hypersensitivity skin test was performed during week 10. All 
horses were treated similarly. 
 
Leukotriene B4 and Bs Quantification 
Neutrophils were isolated and purified as previously described from blood collected at 0 and 12 
weeks of the study.12 Aliquots of 1 X 10' neutrophils were transferred to 5-mL polypropylene 
tubes and the volume was adjusted to 495 with Hank's balanced salt solution containing 0.8 
mmol/L CaCI„ Neutrophils were then stimulated with 5 of calcium ionophore A23187' in 0.2% 
dimethyl sulfoxide' such that the final concentration of A23187 was 10 μmol/L, while unstithat 
the final concentration of A23187 was 10 μmol/L, while unstimutated PMN received 5 of 0.2% 
dimethyl sulfoxide without calcium ionophore. All tubes were incubated for 5 minutes in a 37°C 
water bath and the reaction was terminated by addition of 2 mL of ice-cold methanol to each 
tube and incubation on ice for 20 minutes. Tubes were centrifuged for 5 minutes at 1000 X g, 
and supernatants were transferred to 5-mL polypropylene tubes and stored at —70°C until 
subsequent LIB4 and LTB5 measurements were made. 
 
Leukotrienes were extracted and separated using a modified version of methods described by 
Terano et al
13
 and Vaughn et al.
14
 Stored supernatants from the leukotriene stimulation procedure 
were centrifuged for 5 minutes at 400 X g and transferred to 15-mL centrifuge tubes. 
Prostaglandin B3
h
 (100 ng), which served as an internal standard, was added to each sample 
before extraction. Citrate buffer (pH 4.0) was added to achieve a final volume of 14.5 mL. 
Samples were loaded onto an activated C-18 solid-phase extraction cartridge by gravity flow. 
Cartridges were rinsed with 5 mL of distilled-deionized (dd)-H20 followed by 5 mL of high-
performance liquid chromatography (HPLC)-grade hexane. Leukotrienes were eluted using 5 mL 
of a methanol: dd-H20 mixture (90v : 10v) by gravity flow into 5-mL polypropylene tubes. Tubes 
were placed in a 30°C water bath and the eluate was evaporated under a stream of N2. Residues 
were reconstituted in 125 μl of mobile phase (methanol: water : glacial acetic acid [75 : 25 : 01], 
pH adjusted to 5.7 with NH4,OH), capped with N, and stored at —70°C until separation by 
HPLC. 
 
Leukotrienes B4 and B5 were separated by HPLC using a C-18 reversed-phase column
j
 fitted 
with a C-18 guard column.
k
 The mobile phase was methanol: water : glacial acetic acid (75 : 25 : 
01), and pH was adjusted to 5.7 with NH2OH. Flow rate of the pump
l
 was set at 0.7 mL/min and 
the variable wavelength UV detector
m
 was fixed at 254 nm. 
 
Elution times were determined using PGB3, LTB5, and LIB4, standards,
h
 and sample fractions 
were collected from 6.2 to 8.0 minutes for LTB, and from 8.5 to 10.3 minutes for LTB5. 
Fractions were also collected at the start (0 to 6.2 minutes) and end (10.3 to 15 minutes) of each 
run and between leukotriene fractions (8.0 to 8.5 minutes). The latter were analyzed to ascertain 
that they did not contain leukotriene. Fractionated samples were capped with N2 and stored at —
70°C for subsequent analysis by enzyme immunoassay (EIA). Peaks were integrated using an 
integrator.
n 
 
Concentrations of LTB4 and LTB5 in samples were determined using EIA kits
h
 Samples obtained 
from the HPLC separation of leukotrienes were placed in a 37°C water bath and evaporated to 
dryness under a stream of N2. Samples were then reconstituted in 150 of EIA buffer and stored at 
4°C until they were assayed by EIA according to the manufacturer's instructions. All samples 
were analyzed in duplicate and plates were read when a maximum binding well reached an 
optical density (O.D.) of 0.500. The O.D. of each well at 405 nm was determined using a Bio-
Tek EL312 microplate reader.
o
 The antiserum that was used had a cross-reactivity of 100% for 
LIB4 and 50% for LTB5. An additional standard curve for LTB5, was prepared in the same man-
ner as the LTB4, standard to accurately quantify LTB5. Concentrations for LTB4 and LTB5 were 
calculated using the software program Kinetic Cale version 2:12.
o 
 
Other Chemical Assays 
Fatty acid profiles were determined by gas chromatography as previously described
15
 using 
heptadecanoic acid as the internal standard. Fatty acid concentration was expressed as g/100 g 
fatty acids. Plasma α-tocopherol content was measured by HPLC using a fluorometric detector 
and expressed as μmol/L and μmol/mmol lipid.
9
 Plasma concentrations of cholesterol and 
triacylglycerol were determined enzymatically by methods previously discussed.
9
 Total plasma 
lipid content was described as the sum of cholesterol and triacylglycerol concentrations.
16
 Serum 
biochemistries were analyzed at 0, 8, and 12 weeks using a Roche FARA II system.
p
 Measured 
serum analytes included urea nitrogen, creatinine, glucose, total protein, albumin, total bilirubin, 
creative kinase, gamma-glutamyltranspeptidase, aspartate aminotransferase, sodium, potassium, 
chloride, calcium, phosphorus, magnesium, and sorbitol dehydrogenase. 
 
Statistical Analysis 
The trial was a completely randomized design. Using the Kolmogorov-Smirnov and Cramer-von 
Mises tests, all data were found to be normally distributed. Data were analyzed using the 
MIXED procedure of Statistical Analysis Systems for repeated measures.'' Main effects were 
diet, week, and their interaction analyzed over time. Because of differences in initial body weight 
among horses, initial body weight was used as a covariate in all models, but was dropped from 
final models because it was found to be not significant. For each dependent variable, a horse 
nested in treatment (diet) was subjected to differing covariance structures. The best model fit was 
determined by lowest parameter values for covariance structure. For main effects found to be 
significant, mean differences were determined by pairwise differences or probability values for 
differences of the least-squares means (PDIFF) for preplanned comparisons.
17
 Data are reported 
as least square means ± SEM unless otherwise indicated. A two-sample t-test was used to 
compare leukotriene data. Values were considered significant at P .05 unless otherwise indicated. 
 
RESULTS 
Animals and Diets 
All horses readily consumed the oil-enriched diets, and weekly food consumption (measured as a 
percentage of amount fed) was calculated to be greater than 95% for both groups of horses 
throughout the study. One horse in the fish oil group had decreased food consumption (25 to 
50%) beginning the 10th week of the feeding trial, which lasted through the end of the feeding 
period. At week 12, complete blood count (CBC) results from this horse exhibited neutrophilia 
with left shift. Given the implication of an active inflammatory process, data from this horse for 
weeks 8 and 12 were excluded. For all other horses, the results of serial CBCs (data not shown) 
and serum biochemistry measures were within established reference intervals for normal animals 
and, thus, were interpreted to suggest that all animals were healthy and free of obvious 
inflammatory disease. Significant oxidation of oils at the beginning or end of the feeding trial 
was not detected based on peroxide and p-anisidine values. 
 
Initial body weight was used as a covariate in all statistical models. Initial mean body weight for 
horses fed fish oil fed was 542 ± 13 kg, and for horses fed corn oil it was 477 ± 13 kg. All horses 
gained body weight during the first 4 weeks of the study, then lost weight, such that body 
weights from week 7 through the end of the study were not different from initial body weights. 
Thus, net change in body weight across time was not influenced by diet, nor was average daily 
body weight change. 
 
Plasma Fatty Acid Profiles 
There were no major differences in plasma (n-6) and (n3) fatty acid compositions between horses 
at the beginning of the study. Plasma fatty acid profiles showed significant changes 6 weeks after 
supplementation began with corn oil or fish oil (Table 2). In general, changes noted in the plasma 
fatty acid profiles at 6 weeks persisted through 12 weeks. Horses that consumed the corn oil 
supplement had a 29% increase in plasma (n-6) fatty acids at 6 weeks that persisted at 8 and 12 
weeks, and no change in plasma (n-3) fatty acids. Conversely, horses consuming the fish oil 
supplement showed a 24% decrease in plasma (n-6) fatty acids at 6 weeks, with marked 
increases in plasma concentrations of total (n-3) fatty acids at 6, 8, and 12 weeks compared with 
baseline. Thus, horses fed fish oil had higher concentrations of (n-3) fatty acids than horses fed 
corn oil at 6, 8, and 12 weeks. 
 
The calculated ratio between (n-6) and (n-3) fatty acids in plasma was not different between 
treatment groups at baseline. In corn oil—fed horses, the (n-6) to (n-3) fatty acid ratio was 
increased at 6, 8, and 12 (highest) weeks of the study compared with week 0. In contrast, fish 
oil—fed horses showed a marked decline in (n-6) to (n-3) fatty acid ratio from week 0 to 6 and 8 
weeks. At 12 weeks, it was not different from baseline. 
 
Before beginning corn oil or fish oil supplementation, linoleic acid made up the largest 
percentage of the total plasma PUFA in both groups of horses. After feeding horses the corn oil 
supplement, there was an increase in plasma linoleic acid at 6 weeks from the baseline value. 
This change persisted through 8 and 12 weeks, but returned to pretrial levels 4 weeks after 
discontinuing supplementation. However, in horses fed fish oil, there was a decrease in plasma 
linoleic acid at 6, 8, and 12 weeks, which persisted even after discontinuing the oil supplements 
(18 weeks). 
 
Fish oil—fed horses showed increased plasma AA, EPA, and DHA concentrations compared 
with corn oil—fed horses. Plasma levels of AA, EPA, and DHA were decreasing by 18 weeks (4 
weeks after discontinuing the fish oil supplement), although AA and DHA concentrations were 
still higher than baseline. Corn oil—fed horses showed no change in plasma concentrations of 
AA, EPA, or DHA over time. Plasma concentrations of α-linolenic acid were decreased Plasma 
concentrations of α-linolenic acid were decreased in horses from both groups at 6, 8, and 12 
weeks compared with baseline values, but returned to baseline values at 18 weeks. 
 
Plasma concentrations of total saturated fatty acids (SFA) were decreased at 6 and 8 weeks from 
baseline values in the corn oil—supplemented horses. No significant differences in plasma total 
SFA were noted between the 2 groups of horses. The SFA 16 : 0 and 22 : 0 were significantly 
different between the 2 groups of horses at 6 and 8 weeks (also at 12 weeks for 22 : 0), with 
horses fed fish oil supplements having higher concentrations of each. 
 
In general, horses fed fish oil supplements had higher concentrations of monounsaturated fatty 
acids (MUFAs) compared with horses fed corn oil supplements, although total MUFAs 
decreased in horses from both diet groups and remained lower than baseline levels at 6, 8, and 12 
weeks. Four weeks after discontinuing the fatty acid supplements (18 weeks), plasma 
concentrations of MUFAs increased in both groups of horses, but remained decreased from base-
line in the corn oil—fed horses. 
 
Plasma Cholesterol, Triacylglycerol, α-Tocopherol 
Mean plasma cholesterol concentrations were not different between horses fed corn oil and 
horses fed fish oil at any time point. Across both diets, plasma concentrations were lowest at 
week 0, greatest at week 6, and weeks 8 and 12 were equivalent with both means being lower 
than week 6 (Table 3). Mean plasma triacylglycerol concentrations were not influenced by 
dietary treatment. Plasma triacylglycerol was highest at week 0 compared with weeks 6 and 12, 
but not different from week 8. Plasma α-tocopherol 12, but not different from week 8. Plasma α-
tocopherol concentration increased at week 6 compared with week 0 in both groups of horses 
and remained elevated at weeks 8 and 12. When plasma α-tocopherol concentrations were 
presented on a total lipids basis, horses fed corn oil supplement had a higher plasma α-tocopherol 
to total lipids ratio compared with fish oil—fed horses at all time points. Similar to α-tocopherol 
concentrations, the α-tocopherol to total lipids ratio at week 0 was the lowest compared with all 
other time points. Because horses fed corn oil had a higher plasma α-tocopherol to total lipids 
ratio compared with fish oil—fed horses at week 0, initial values were also used as a covariate to 
test for differences between diets across time. Covariate analysis showed no dietary effect. 
 
LTB4 and LTB5 Quantification 
Neither LTB. LTB, production by stimulated peripheral blood neutrophils was significantly 
different between the 2 groups of horses at week 0 (Fig 1). Although LTB4 and LTB5 production 
within the group of horses fed corn oil increased slightly (nonsignificant) from baseline to week 
12, the horses fed fish oil had a significant increase in production of both leukotrienes at 12 
weeks. The ratio of LTB5 to LTB4 was also significantly higher at 12 weeks compared with 
baseline values within the group of horses fed fish oil. 
 
The ratio of EPA to AA in the plasma across dietary treatments and time periods (weeks 0 and 
12) was correlated (correlation coefficient = 0.90, P < .0001) to the ratio of LTB, to LTB, After 
feeding horses a corn oil supplement for 12 weeks, the EPA : AA ratio was not different from 
that of week 0. However, after feeding horses a fish oil supplement for 12 weeks, the ratios for 
EPA : AA and LTB5 : LTB4 were both significantly increased compared with those at week 0 
(4.6-fold and 9.4-fold, respectively). 
 
Serum Chemistries 
For all serum analytes measured, only calcium and magnesium were influenced by dietary 
treatment (Table 4). Overall, mean serum calcium concentration was greater for horses fed fish 
oil compared with corn oil supplements, with mean calcium concentrations across diets being 
highest at 12 weeks. Serum calcium concentrations in corn oil— fed horses declined from week 
0 to week 8 and then increased at week 12. In contrast, fish oil—fed horses showed a tendency 
for a linear increase in serum calcium concentrations over time. Overall, the mean serum 
magnesium concentration was greater for corn oil—fed horses than for fish oil—fed horses. 
Mean serum magnesium concentrations across diets declined with time. Fish oil—fed horses 
exhibited a linear decline in serum magnesium concentrates, 
 
 
whereas corn oil—fed horses showed a decline from week 0 to week 8, and no difference 
between weeks 8 and 12. Other serum analytes measured were all within expected normal ranges 
for mature horses. 
 
Discussion 
All horses readily consumed their corn oil or fish oil supplements. As expected, plasma fatty acid 
profiles of horses reflected PUFA content of the oils fed. Total plasma (n-6) PUFA increased in 
horses fed corn oil, whereas total plasma (n-3) PUFA increased in horses fed fish oil with a 
concomitant decrease in plasma (n-6) PUFA. Although horses that consumed the corn oil 
supplement had an increase in linoleic acid, they did not have a corresponding increase in plasma 
AA. Paradoxically, horses that consumed the fish oil supplement had an increase in plasma AA, 
which appeared to reflect the presence of AA in the fish oil supplement. The increase in plasma 
AA in horses fed the fish oil supplement was inconsistent with results of other studies, using 
other animal species.
18-20 
 
Other researchers have reported similar results to ours when horses were fed an (n-6) fatty acid 
supplement.
21
 Plasma phospholipid profiles in that study were determined after 10 and 16 
months of dietary supplementation with (n-6) PUFA. The amount of linoleic acid was, 
interestingly, 36 to 45 times higher compared to that of AA in plasma phospholipids. In addition, 
analysis of cholesterol esters, triglycerides, and free fatty acid revealed no detectable AA levels. 
In our study, plasma linoleic acid concentrations were 50- to 95-fold higher than AA 
concentrations in horses fed the (n6) fatty acid supplement. These data suggest that AA is not 
readily synthesized from linoleic acid in horses. 
 
In another study, horses were fed a flaxseed oil—supplemented pellet for 16 weeks, and plasma 
linoleic acid concentrations increased because flaxseed oil had a high concentration of linoleic 
acid in addition to α-linolenic acid.'" Similar tion of linoleic acid in addition to α-linolenic acid.
21 
Similar to the results we report here, plasma AA levels in those flaxseed oil—supplemented 
horses were not increased in association with increased plasma linoleic concentrations. 
 
Linoleic acid remained elevated in plasma of horses fed diets enriched in corn oil throughout the 
12-week dietary supplementation period. One explanation for why horses that consumed the corn 
oil supplement had higher levels of plasma linoleic acid without an increase in plasma AA levels 
is that linoleic acid was not metabolized to AA by these horses. The enzymes involved in 
conversion of linoleic acid to AA include Δ6 desaturase, Δ5 desaturase, and an elongase. In our 
study, horses fed the corn oil supplement had very low plasma concentrations of fatty acids 
derived from enzymatic action of these enzymes. The high plasma linoleic acid concentration in 
this group of horses reflects the large amount of linoleic acid that was contained in the corn oil 
supplement. The increase in plasma AA concentrations noted in horses fed fish oil was more 
likely a result of exogenous AA contained in the fish oil. Activity of the Δ6deexogenous AA 
contained in the fish oil. Activity of the Δ6desaturase enzyme is affected by concentrations of (n-
6) and (n-3) PUFA. Fatty acids that are substrates for this enzyme, 18 : 2(n-6) and 18: 3(n-3), can 
competitively inhibit metabolism of each other.
23
 It is also possible that horses lack one or more 
of the enzymes involved in conversion of 
 
linoleic acid to AA. This phenomenon has previously been documented in wild and domestic 
cats 
24- 26
 The Δ6 desaturase enzyme is the first enzyme in the metabolic pathway from linoleic 
acid to AA. It is also the rate-limiting enzyme; thus, it limits conversion of linoleic acid to AA 
even though there may be an abundance of linoleic acid in plasma. 
 
Four weeks after the diets were discontinued, plasma fatty acid profiles were similar to those 
observed before dietary intervention. This study shows that plasma fatty acid profiles in horses 
are altered after 6 weeks of dietary fatty acid supplementation, and that changes return to 
predietary levels by 4 weeks after discontinuing fatty acid supplementation. 
 
Horses in this study received a vitamin/mineral supplement that provided 800 IU of α-
tocopherol/day to each ment that provided 800 IU of α-tocopherol/day to each horse. Plasma α-
tocopherol measurements in our horses showed that plasma concentrations of α-tocopherol 
exceeded 2.0 μg/mL after 12 weeks of PUFA supplementation, which is considered the 
minimally adequate level for horses.
27
 Some studies,
28
 but not necessarily al1,
29
 have shown that 
high intakes of (n-3) fatty acids lower plasma concentrations of α-tocopherol. In our study, 
dietary α-tocopherol supplementation of 800 IU/day resulted in increased plasma concentration 
of α-tocopherol in both groups of horses. 
 
Plasma α-tocopherol concentrations were also expressed Plasma α-tocopherol concentrations 
were also expressed as a mass ratio between α-tocopherol and total lipid (cho- 
 
lesterol and triglyceride), because this provides the most accurate indicator of plasma α-
tocopherol concentration.curate indicator of plasma α-tocopherol concentration.
16,30
 The ratio of 
α-tocopherol to total lipids was increased in corn oil—supplemented horses compared with fish 
oil—supplemented horses before dietary oil supplementation began (week 0). Although this ratio 
increased with time in both groups of horses, it remained higher in the group of horses 
supplemented with corn oil at 6, 8, and 12 weeks. It is likely that this difference between groups 
represented group/animal effects present at the initial sampling time (week 0) that persisted. We 
have previously shown in dogs that plasma αtocopherol concentration is not dependent on 
dietary ratio of (n-6) and (n-3) fatty acids when α-tocopherol is expressed relative to the total 
lipid content of plasma.
30 
 
Supplementing the horse diet with either (n-6) or (n-3) fatty acids increased plasma cholesterol 
concentrations, which differs from human beings and dogs. 
18-31
 Plasma triglyceride 
concentrations were not different between the two groups of horses; however, both groups had 
decreased triglyceride concentrations after 12 weeks of supplementation compared with baseline 
values. Fish oil supplementation in humans is also associated with a reduction in triglyceride 
levels.
31
 The results of the current study differ from the results of another study,
22
 which showed 
no change in serum triglyceride concentrations after horses were fed flaxseed oil—supplemented 
pellets for 16 weeks. 
 
The production of LTB5 and LTB4 from equine peripheral blood neutrophils reflects the plasma 
concentration of substrates EPA and AA, respectively, from which they are derived. Dietary 
supplementation of horses with fish oil resulted in high plasma concentrations of EPA and DHA 
and, unexpectedly, high plasma concentrations of AA. Consequently, those horses fed fish oil 
supplements had higher levels of the corresponding leukotrienes (LTB5 and LTB4). Dietary 
supplementation of horses with corn oil resulted in high plasma concentrations of linoleic acid, 
but not AA. It is apparent that horse neutrophils stimulated with calcium ionophore do not 
readily produce LTB4 in the absence of AA. Conversely, neutrophils from dogs fed 5 :1 and 10 : 
1 (n-6) to (n-3) fatty acid ratios synthesized 30 to 33% less LTB4 and 370 to 500% greater LTB5 
after 6 and 12 weeks of feeding compared with week 0. This decrease in LTB4 production by 
neutrophils from dogs fed foods with low (n6) to (n-3) fatty acid ratios is consistent with the 
decrease in plasma AA concentration in dogs fed fish oil supplements,18 and differs from the 
increase in plasma AA concentrations and increase in LTB4 production by neutrophils from 
horses fed fish oil supplements reported here. 
 
In another study, stimulated monocytes from horses fed a pelleted ration that contained 8% 
linseed oil for 8 weeks produced less LTB4 than control horses.
32
 Our fish oil—supplemented 
horses had increased plasma AA, which likely contributed to increased production of LTB4. The 
type of cells stimulated, differences in dietary fat concentrations and source, and different 
methodologies used to determine fatty acid content (plasma versus monocyte cell membranes) 
may account for the observed differences between these two studies. 
 
It has been shown that exogenous AA is necessary for cultured equine neutrophils to produce 
leukotrienes when stimulated with calcium ionophore.
33
 Results of our study suggest that a diet 
rich in (n-3) PUFA caused an increase in production of LTB4 likely because AA from fish oil is 
incorporated into cell membrane phospholipids. However, a diet rich in (n-3) PUFA also 
increased production of LTB5 which is less biologically active than LTB4, and may have 
inhibitory effects on the function of LTB4.
33
 Thus, it is unclear to what extent increased 
production of LTB4 in the horse may be harmful, based on concurrent increased production of 
LTB5 
 
In the current study, horses consuming fish oil supplements showed a strong correlation 
(correlation coefficient = 0.93) between the ratio of EPA to AA in plasma and the ratio of LTB5 
to LTB4 synthesized by stimulated neutrophils. Similarly, a linear relationship has been 
demonstrated between the ratio of EPA to AA in cell membrane phospholipids and the ratio of 
LTB5 to LTB4 produced by rat peritoneal exudate cells in vitro.20 In horses consuming the fish 
oil supplement, the ratio of plasma EPA to AA and the ratio of LTB5 to LTB4 production both 
increased with time, and ratios were higher in horses receiving the fish oil supplement than in 
horses receiving the corn oil supplement. The strength of the correlation in horses fed fish oil 
compared with horses fed corn oil would suggest that dietary manipulation of fat has a direct 
effect on the LTB5 to LTB4 ratio. Corn oil supplements had no added AA or EPA, and the LTB5 
to LTB4 ratio was dependent on previously incorporated membrane fatty acids. If the ratio of 
LTB, to LTB, is important in horses as it is in other species,20, 34-36 then an equine diet high in 
(n-3) PUFA is preferable to a diet high in (n-6) PUFA in terms of decreasing proinflammatory 
leukotriene synthesis. 
 
Giving horses a supplement of fish oil for 12 weeks resulted in increased serum calcium and 
decreased serum magnesium concentrations, whereas supplementation with corn oil over the 
same period resulted in decreased serum magnesium. However, all values were within expected 
normal ranges for mature horses. For all other serum chemistries measured, no effects of corn or 
fish oil supplementation were found, which is consistent with the results of other studies.
22 
 
In summary, we have shown that supplementation with fish oil not only increased production of 
the proinflammatory eicosanoid LTB4, but also increased production of the less inflammatory 
eicosanoid LTB5. The ratio of plasma EPA to AA corresponded with the ratio of LTB5 to LTB4 
produced by stimulated equine neutrophils. If the ratio of LTB5 to LTB4 concentrations is 
important in determining how inflammatory processes are mediated, then investigations should 
be conducted to determine the optimum ratio of LTB5 to LTB4 to decrease inflammation. 
 
Footnotes 
a. Pyrantel pamoate, Strongid Paste, Pfizer, Inc., U.S. Animal Health Operations, New 
York, NY 
b. Kindly provided by Omega Protein Inc., Reedville, VA 
c. Mazola, CPC International, Englewood Cliffs, NJ 
d. Horse Guard Inc., Redmond, OR 
e. Dairy One Laboratory, Ithaca, NY 
f. Sigma Chemical Co., St. Louis, MO 
g. DMSO, Syntex, West Des Moines, IA 
h. Cayman Chemical_ Co., Ann Arbor, Mt 
i. Sep-Pak Classic, Waters Inc., Milford, MA 
j. Nova-pak, 3.9 mm X 300 mm, 60A pore size, 4 p.m particle size, Waters Inc., Milford, 
MA 
k. Nova-pak Sentry, 3.9 mm X 20 mm, Waters Inc., Milford, MA   
l. Model HOB, Beckman, Fullerton, CA 
m. System Gold Model 166, Beckman, Fullerton, CA 
n. Perkin Elmer LC1-100 Laboratory Computing Integrator, Boston, MA   
o. Bio-Tek Instruments Inc., Winooski, VT 
p. Roche Inc., Somervdle, NJ 
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